DTect-All(TM) platform will be used to screen for GPCR-directed allosteric modulator antibodies Domain Therapeutics, a biopharmaceutical company specializing in the research and development of new drug candidates targeting G ...
Tags: DTect-All(TM)
The Agency for Science, Technology and Research (A*STAR)'s Experimental Therapeutics Centre (ETC) and Swiss biopharmaceutical firm Debiopharm Group (Debiopharm) have signed an exclusive research collaboration to develop oral small molecules ...
Tags: Cancer Drugs, Medicine
Pfizer has collaborated with the University of California, San Francisco (UCSF) to expand its centers for therapeutic innovation (CTI) into the development of small-molecule drug candidates and enhance its drug discovery capabilities. ...
Inventiva and Novalix have entered into a strategic alliance to discover the clinical candidates, targeting nuclear receptors. As part of the agreement, Inventiva and NovAliX offer pharmaceutical and biotech companies a set of fully ...
Tags: NovAliX, clinical candidates